{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:01:38Z","timestamp":1790359298110,"version":"4.1.0"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000061","name":"Fogarty International Center","doi-asserted-by":"publisher","award":["2D43TW009771-06"],"award-info":[{"award-number":["2D43TW009771-06"]}],"id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001713","name":"European and Developing Countries Clinical Trials Partnership","doi-asserted-by":"publisher","award":["EDCTP-RegNET2015-1104"],"award-info":[{"award-number":["EDCTP-RegNET2015-1104"]}],"id":[{"id":"10.13039\/501100001713","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosglobalpublichealth.org"],"crossmark-restriction":false},"short-container-title":["PLOS Glob Public Health"],"abstract":"<jats:p>Data on the safety of tuberculosis preventive treatment (TPT) during pregnancy particularly from routine care settings in high tuberculosis (TB) burden countries remain limited. We evaluated the association between TPT exposure during pregnancy and adverse pregnancy outcomes among pregnant women living with HIV (WLHIV) in Uganda. We conducted a retrospective cohort study using routinely collected data from five public urban primary health facilities in Kampala, Uganda. We included pregnant women living with HIV on antiretroviral therapy (ART) between 2016 and 2022. The primary outcome was a composite of adverse pregnancy outcomes: miscarriage, stillbirth, low birth weight, neonatal complications, or maternal\/neonatal death. A secondary composite outcome excluded neonatal and maternal death. There was no preterm delivery documented in this sample. The primary exposure was 6-month isoniazid preventive therapy (IPT) during pregnancy. We applied inverse probability of treatment weighting (IPTW) using propensity scores from logistic regression to adjust for confounding. Missing data on covariates and outcome were addressed using multiple imputation. Analysis was performed using R software v.4.3.3. We analyzed data from 521 pregnant WLHIV, the median age was 28 years (interquartile range 24\u201331), 44% of whom received IPT during pregnancy. Overall, 10.0% experienced an adverse pregnancy outcome. No significant differences were observed between IPT-exposed and unexposed groups for the primary (10.3% vs. 9.6%; p\u2009=\u20090.81) or secondary (10.3% vs. 8.5%; p\u2009=\u20090.50) composite outcomes. IPTW-adjusted analysis showed no significant association between IPT exposure and adverse pregnancy outcomes (weighted OR: 1.06; 95% CI: 0.68\u20131.63; p\u2009=\u20090.81). Sensitivity and subgroup analyses yielded consistent findings. Exposure to 6-month isoniazid TPT during pregnancy was not statistically associated with adverse pregnancy outcomes among women on ART in routine care settings. Strengthened pharmacovigilance and systematic clinical reporting are essential to ensure maternal and neonatal safety as TPT coverage expands in high TB\/HIV burden settings.<\/jats:p>","DOI":"10.1371\/journal.pgph.0005829","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:42:29Z","timestamp":1790358149000},"page":"e0005829","update-policy":"https:\/\/doi.org\/10.1371\/journal.pgph.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Isoniazid monotherapy for tuberculosis prevention during pregnancy and adverse outcomes in women living with HIV in Uganda: A propensity score\u2013weighted analysis of routine care data"],"prefix":"10.1371","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5245-4571","authenticated-orcid":true,"given":"Joseph","family":"Musaazi","sequence":"first","affiliation":[{"name":"Infectious Diseases Institute, School of Medicine, College of Health Sciences, Makerere University","place":["Kampala, Uganda"]},{"name":"Global Health Institute","place":["Antwerp, Belgium"],"department":["Faculty of Medicine and Health Science"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Sekaggya-Wiltshire","sequence":"additional","affiliation":[{"name":"Infectious Diseases Institute, School of Medicine, College of Health Sciences, Makerere University","place":["Kampala, Uganda"]},{"name":"University of St Andrews","place":["St Andrews, Scotland, United Kingdom"],"department":["School of Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8823-7082","authenticated-orcid":true,"given":"Stella","family":"Zawedde-Muyanja","sequence":"additional","affiliation":[{"name":"Infectious Diseases Institute, School of Medicine, College of Health Sciences, Makerere University","place":["Kampala, Uganda"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Proscovia M.","family":"Namuwenge","sequence":"additional","affiliation":[{"name":"National Tuberculosis and Leprosy Program","place":["Kampala, Uganda"],"department":["Uganda Ministry of Health"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Sanni","family":"Ali","sequence":"additional","affiliation":[{"name":"LSHTM","place":["London, United Kingdom"],"department":["Department of Disease Control"]},{"name":"VIBRANIUM RESOURCES Foundation","place":["Addis Ababa, Ethiopia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukari C.","family":"Manabe","sequence":"additional","affiliation":[{"name":"Infectious Diseases Institute, School of Medicine, College of Health Sciences, Makerere University","place":["Kampala, Uganda"]},{"name":"Johns Hopkins University School of Medicine","place":["Baltimore, Maryland, United States of America"],"department":["Division of Infectious Diseases, Department of Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Castelnuovo","sequence":"additional","affiliation":[{"name":"Infectious Diseases Institute, School of Medicine, College of Health Sciences, Makerere University","place":["Kampala, Uganda"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nele","family":"Brusselaers","sequence":"additional","affiliation":[{"name":"Global Health Institute","place":["Antwerp, Belgium"],"department":["Faculty of Medicine and Health Science"]},{"name":"Karolinska Institutet","place":["Stockholm, Sweden"],"department":["Department of Women\u2019s and Children\u2019s Health"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"key":"pgph.0005829.ref001","author":"World Health Organization","year":"2023"},{"issue":"18","key":"pgph.0005829.ref002","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1097\/QAD.0b013e32832e34b1","article-title":"Increased risk of hepatotoxicity in HIV-infected pregnant women receiving antiretroviral therapy independent of nevirapine exposure","volume":"23","author":"DW Ouyang","year":"2009","journal-title":"AIDS"},{"issue":"3","key":"pgph.0005829.ref003","doi-asserted-by":"crossref","first-page":"1901967","DOI":"10.1183\/13993003.01967-2019","article-title":"The safety of isoniazid tuberculosis preventive treatment in pregnant and postpartum women: systematic review and meta-analysis","volume":"55","author":"Y Hamada","year":"2020","journal-title":"Eur Respir J"},{"issue":"14","key":"pgph.0005829.ref004","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1056\/NEJMoa1813060","article-title":"Isoniazid Preventive Therapy in HIV-Infected Pregnant and Postpartum Women","volume":"381","author":"A Gupta","year":"2019","journal-title":"The New England Journal of Medicine"},{"key":"pgph.0005829.ref005","unstructured":"UNAIDS Country Specific Factsheets for Uganda 2023. https:\/\/www.unaids.org\/en\/regionscountries\/countries\/uganda. 2023."},{"key":"pgph.0005829.ref006","unstructured":"Commission UA. Abridged 2025 Uganda HIV and AIDS Factsheet. 2025."},{"key":"pgph.0005829.ref007","unstructured":"Uganda Ministry of Health. The Uganda National Tuberculosis Prevalence Survey, 2014-2015. 2017."},{"key":"pgph.0005829.ref008","doi-asserted-by":"crossref","unstructured":"Mathad JS, Gupta A. Tuberculosis in pregnant and postpartum women: epidemiology, management, and research gaps. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2012;55(11):1532\u201349.","DOI":"10.1093\/cid\/cis732"},{"issue":"2","key":"pgph.0005829.ref009","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1086\/518974","article-title":"Postpartum Tuberculosis Incidence and Mortality among HIV-Infected Women and Their Infants in Pune, India, 2002\u20132005","volume":"45","author":"A Gupta","year":"2007","journal-title":"Clinical Infectious Diseases"},{"key":"pgph.0005829.ref010","unstructured":"Uganda Ministry of Health. Isoniazid Preventive Therapy in Uganda - A Health Worker\u2019s Guideline. 2014."},{"key":"pgph.0005829.ref011","unstructured":"Uganda Ministry of Health. 100-Day Accelerated Isoniazid Preventive Therapy Scale Up Plan. 2019."},{"key":"pgph.0005829.ref012","author":"Uganda Ministry of Health","year":"2021"},{"issue":"3","key":"pgph.0005829.ref013","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3201\/eid2903.221353","article-title":"Tuberculosis Preventive Therapy among Persons Living with HIV, Uganda, 2016-2022","volume":"29","author":"D Lukoye","year":"2023","journal-title":"Emerging Infectious Diseases"},{"issue":"2","key":"pgph.0005829.ref014","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0268935","article-title":"Increased uptake of tuberculosis preventive therapy (TPT) among people living with HIV following the 100-days accelerated campaign: A retrospective review of routinely collected data at six urban public health facilities in Uganda","volume":"18","author":"J Musaazi","year":"2023","journal-title":"PLoS One"},{"issue":"8","key":"pgph.0005829.ref015","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciz1224","article-title":"Safety and Effectiveness of Isoniazid Preventive Therapy in Pregnant Women Living with Human Immunodeficiency Virus on Antiretroviral Therapy: An Observational Study Using Linked Population Data","volume":"71","author":"E Kalk","year":"2020","journal-title":"Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America"},{"issue":"11","key":"pgph.0005829.ref016","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa1482","article-title":"Individual and Composite Adverse Pregnancy Outcomes in a Randomized Trial on Isoniazid Preventative Therapy Among Women Living With Human Immunodeficiency Virus","volume":"72","author":"G Theron","year":"2021","journal-title":"Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America"},{"key":"pgph.0005829.ref017","doi-asserted-by":"crossref","unstructured":"World Health Organization. WHO consolidated guidelines on tuberculosis. Module 1: prevention \u2013 tuberculosis preventive treatment. 2020.","DOI":"10.30978\/TB2021-2-86"},{"key":"pgph.0005829.ref018","article-title":"Prevention, diagnosis, and treatment of tuberculosis in children and mothers: evidence for action for maternal, neonatal, and child health services","author":"H Getahun","year":"2012","journal-title":"J Infect Dis"},{"key":"pgph.0005829.ref019","unstructured":"Uganda Ministry of Health. Consolidated guidelines for prevention and treatment of HIV in Uganda. 2016."},{"key":"pgph.0005829.ref020","unstructured":"Kit OD. Open Data Kit Documentation. https:\/\/docs.opendatakit.org"},{"key":"pgph.0005829.ref021","unstructured":"Uganda Ministry of Health METS. Uganda Electronic Medical Records (EMR) System User Manual. https:\/\/github.com\/METS-Programme\/ugandaemr-usermanual"},{"key":"pgph.0005829.ref022","author":"Uganda Ministry of Health","year":"2022"},{"key":"pgph.0005829.ref023","unstructured":"Uganda Ministry of Health. Consolidated Guidelines for Prevention and Treatment of HIV in Uganda. 2022."},{"key":"pgph.0005829.ref024","volume-title":"The Developing Human. Clinically Oriented Embryology","author":"K Moore","year":"2020","edition":"11"},{"issue":"10","key":"pgph.0005829.ref025","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s40264-024-01445-1","article-title":"Pharmacovigilance in pregnancy studies, exposures and outcomes ascertainment, and findings from low- and middle-income countries: A scoping review","volume":"47","author":"J Shafi","year":"2024","journal-title":"Drug Safety"},{"key":"pgph.0005829.ref026","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/1471-2458-7-268","article-title":"Under-attending free antenatal care is associated with adverse pregnancy outcomes","volume":"7","author":"K Raatikainen","year":"2007","journal-title":"BMC Public Health"},{"issue":"7","key":"pgph.0005829.ref027","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0235626","article-title":"Predictors of low birth weight and preterm birth in rural Uganda: Findings from a birth cohort study","volume":"15","author":"J Bater","year":"2020","journal-title":"PLoS One"},{"key":"pgph.0005829.ref028","doi-asserted-by":"crossref","first-page":"195637","DOI":"10.1155\/2013\/195637","article-title":"Pregnancy outcomes in HIV-infected women receiving long-term isoniazid prophylaxis for tuberculosis and antiretroviral therapy","volume":"2013","author":"AW Taylor","year":"2013","journal-title":"Infectious Diseases in Obstetrics and Gynecology"},{"issue":"6","key":"pgph.0005829.ref029","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1093\/cid\/ciz1024","article-title":"Isoniazid Preventive Therapy and Pregnancy Outcomes in Women Living With Human Immunodeficiency Virus in the Tshepiso Cohort","volume":"71","author":"N Salazar-Austin","year":"2020","journal-title":"Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America"},{"key":"pgph.0005829.ref030","author":"World Health Organization","year":"2024"}],"container-title":["PLOS Global Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgph.0005829","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:42:40Z","timestamp":1790358160000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgph.0005829"}},"subtitle":[],"editor":[{"given":"Sonali","family":"Sarkar","sequence":"first","affiliation":[{"name":"JIPMER PSM: Jawaharlal Institute of Post Graduate Medical Education and Research Department of Preventive and Social Medicine","place":["INDIA"]}],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":30,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pgph.0005829","relation":{},"ISSN":["2767-3375"],"issn-type":[{"value":"2767-3375","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]}}}